剪切波弹性成像(SWE)用于监测肌腱病治疗:一项双盲纵向临床研究
前瞻性双盲纵向研究纳入35例患者共47条有症状肌腱,在6个月治疗前后行标准化多模态超声与临床评分,以骨科评分为参考标准。SWE检出有症状肌腱的敏感度为87.5%(41/47),高于B型超声的66%(31/47)和能量多普勒超声的72%(34/47)。治疗后SWE检出治疗效应的敏感度为81.3%(26/32),高于B型超声的3.1%(1/32)和能量多普勒超声的28.1%(9/32)。
要点
- SWE检出有症状肌腱的敏感度为87.5%(41/47),阳性预测值为1。
- 治疗后SWE检出治疗效应的敏感度为81.3%(26/32),假阳性率为12.5%(4/32)。
- SWE与临床评分强相关(r=0.80),优于能量多普勒超声(r=0.59)和B型超声(r=0.24)。
核心结论
- 与B型超声或能量多普勒超声不同,SWE能够显示与肌腱愈合相关的过程,可能是有用的监测治疗效应的工具。
研究设计与样本
- 前瞻性、经机构审查委员会批准的纵向临床研究,纳入35例患者共47条有症状肌腱(跟腱17条、髌腱15条、肱骨外上髁肌腱15条),在6个月治疗前后行标准化多模态超声和标准化临床评估;超声由对临床症状不知情的放射科医生使用15 MHz高分辨率线阵探头(Aixplorer)按B型超声、能量多普勒超声、SWE顺序进行,骨科评分作为参考标准。
关键影像表现/征象
- SWE检出有症状肌腱的敏感度为87.5%(41/47),B型超声为66%(31/47),能量多普勒超声为72%(34/47)。
- SWE阳性预测值为1,能量多普勒超声为0.87,B型超声为0.67。
- 治疗后SWE检出治疗效应的敏感度为81.3%(26/32),能量多普勒超声为28.1%(9/32),B型超声为3.1%(1/32)。
- 治疗后SWE假阳性率为12.5%(4/32),能量多普勒超声为46.9%(15/32),B型超声为68.8%(20/32)。
诊断标准与关键数值
- 以骨科评分(跟腱采用维多利亚运动评估问卷、髌腱采用维多利亚运动评估问卷、上肢采用臂肩手功能障碍评分系统)为参考标准评估症状存在、程度及可能缓解。
- SWE检出有症状肌腱的敏感度为87.5%(41/47),特异度原文未报告。
- SWE检出治疗效应的敏感度为81.3%(26/32),假阳性率为12.5%(4/32)。
- 临床评分与SWE findings的相关系数r=0.80,与能量多普勒超声r=0.59,与B型超声r=0.24。
临床应用与阅片要点
- SWE可用于监测肌腱病治疗后的愈合相关改变,其检出治疗效应的敏感度高于B型超声和能量多普勒超声。
- B型超声和能量多普勒超声在检出治疗后变化方面假阳性率较高,SWE假阳性率为12.5%(4/32)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: We aimed to investigate the diagnostic accuracy with which shear wave elastography (SWE) can be used to monitor response to treatment of tendinopathies, and to compare it to conventional ultrasound (US)-imaging methods (B-mode US (B-US) and power Doppler US (PD-US)).
MATERIALS AND METHODS: A prospective Institutional Review Board-approved longitudinal study on 35 patients with 47 symptomatic tendons (17 Achilles-, 15 patellar-, and 15 humeral-epicondylar) who underwent standardized multimodal US and standardized clinical assessment before and after 6 months of treatment (tailored stretching exercise, sport break, and local Polidocanol) was carried out. All US studies were performed by radiologists blinded to the clinical symptoms on both tendon sides to avoid biased interpretations, by B-US, PD-US, and SWE, conducted in the same order, using a high-resolution linear 15 MHz probe (Aixplorer). Orthopedic surgeons who were in turn blinded to US imaging results used established orthopedic scores (Victorian Institute of Sports Assessment questionnaire for Achilles, Victorian Institute of Sports Assessment questionnaire for patellar tendons, and Disability Arm Shoulder Hand scoring system) to rate presence, degree, and possible resolution of symptoms. We analyzed the diagnostic accuracy with which the different US imaging methods were able to detect symptomatic tendons at baseline as well as treatment effects, with orthopedic scores serving as reference standard.
RESULTS: B-US, PD-US, and SWE detected symptomatic tendons with a sensitivity of 66% (31 of 47), 72% (34 of 47), and 87.5% (41 of 47), respectively. Positive predictive value was 0.67 for B-US, 0.87 for PD-US, and 1 for SWE. After treatment, clinical scores improved in 68% (32 of 47) of tendons. Treatment effects were observable by B-US, PD-US, and SWE with a sensitivity of 3.1% (1 of 32), 28.1% (9 of 32), and 81.3% (26 of 32), respectively. B-US was false-positive in 68.8% (20 of 32), PD-US in 46.9% (15 of 32), and SWE in 12.5% (4 of 32) (SWE). Clinical scores and B-US, PD-US, and SWE findings correlated poorly (r = 0.24), moderately (r = 0.59), and strongly (r = 0.80).
CONCLUSION: Unlike B-US or PD-US, SWE is able to depict processes associated with tendon healing and may be a useful tool to monitor treatment effects.
引用
- Dirrichs T, Quack V, Gatz M, et al. Shear Wave Elastography (SWE) for Monitoring of Treatment of Tendinopathies: A Double-blinded, Longitudinal Clinical Study. Acad Radiol. 2017. PMID: 29153963. doi:10.1016/j.acra.2017.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。